Estimation of HIV incidence in the United States

JAMA

Volumn 300, Issue 5, 2008, Pages 520-529

  Hall, H Irene ^a,g   Song, Ruiguang ^a   Rhodes, Philip ^a   Prejean, Joseph ^a   An, Qian ^b   Lee, Lisa M ^a   Karon, John ^c   Brookmeyer, Ron ^d   Kaplan, Edward H ^e   McKenna, Matthew T ^a   Janssen, Robert S ^a,f  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Ginn Group Inc   (United States)

^c Emergint Corporation   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f GILEAD SCIENCES   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CALCULATION; CONFIDENCE INTERVAL; ENZYME IMMUNOASSAY; ETHNIC DIFFERENCE; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES;

EID: 48749117983     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.300.5.520     Document Type: Article

References (46)

1. Institute of Medicine. No Time to Lose: Getting More From HIV Prevention. Washington, DC: National Academy of Sciences; 2000.
2. Biggar RJ, Rosenberg PS. HIV infection/AIDS in the United States during the 1990s. Clin Infect Dis. 1993;17(suppl 1):S219-S223.
3. Rosenberg PS. Backcalculation models of age-specific HIV incidence rates. Stat Med. 1994;13(19-20):1975-1990.
4. Rosenberg PS. Scope of the AIDS epidemic in the United States. Science. 1995;270(5240):1372-1375.
5. Brookmeyer R. Reconstruction and future trends of the AIDS epidemic in the United States. Science. 1991;253(5015):37-42.
6. Karon JM, Fleming PL, Steketee R, De Cock KM. HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health. 2001;91(7):1060-1068.
7. Brookmeyer R, Quinn TC. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. Am J Epidemiol. 1995;141(2):166-172.
8. Parekh BS, Kennedy MS, Dobbs T, et al. Quantitative detection of increasing HIV type I antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses. 2002;18(4):295-307.
9. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA. 1998;280(1):42-48.
10. Bellocco R, Marschner IC. Joint analysis of HIV and AIDS surveillance data in back-calculation. Stat Med. 2000;19(3):297-311.
11. Cui J, Becker NG. Estimating HIV incidence using dates of both HIV and AIDS diagnoses. Stat Med. 2000;19(9):1165-1177.
12. Marschner IC. Using time of first positive HIV test and other auxiliary data in back-projection of AIDS incidence. Stat Med. 1994;13(19-20):1959- 1974.
13. Lee LM, McKenna MT. Monitoring the incidence of HIV infection in the United States. Public Health Rep. 2007;122(suppl 1):72-79.
14. Guidelines for defining public health research and public health non-research. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/od/science/regs/hrpp/researchdefinition.htm. Revised October 4, 1999. Accessed May 7, 2008.
15. Protection of human subjects. 45 CFR §46. Department of Health and Human Services Web site. http://www.hhs.gov/ohrp/documents/OHRPRegulations.pdf. June 23, 2005. Accessed May 7, 2008.
16. Centers for Disease Control and Prevention. Racial/ethnic disparities in diagnoses of HIV/AIDS - 33 states, 2001-2005. MMWR Morb Mortal Wkly Rep. 2007;56(9):189-193.
17. SAS (for Windows) [computer program]. Version 9.1.3. Cary, NC: SAS Institute Inc; 2002.
18. APL*Plus III [computer program]. Rockville, MD: Manugistics Inc; 1995.
19. Karon KM, Song R, Brookmeyer R, Kaplan E, Hall HI. Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results [published online ahead of print August 4, 2008]. Stat Med. doi:10.1002/sim.3144.
20. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: John Wiley & Sons Inc; 1987.
21. Green TA. Using surveillance data to monitor trends in the AIDS epidemic. Stat Med. 1998;17(2):143-154.
22. Song R, Hall HI, Frey R. Uncertainties associated with incidence estimates of HIV/AIDS diagnoses adjusted for reporting delay and risk redistribution. Stat Med. 2005;24(3):453-464.
23. Bishop YMM, Fienberg SE, Holland PW. Discrete Multivariate Analysis. Cambridge, MA: MIT Press; 1975.
24. Population estimates: entire data set. US Census Bureau Web site. http://www.census.gov/popest/estimates.php. July 1, 2006. Accessed November 30, 2007.
25. Bridged-race vintage 2006 postcensal population estimates for July 1, 2000-July 1, 2006, by year, county, single-year of age, bridged-race, Hispanic origin, and sex. National Center for Health Statistics Web site. http://www.cdc.gov/nchs/about/major/dvs/popbridge/datadoc.htm#vintage2006. Accessed December 31, 2007.
26. Hall HI, Li J, Campsmith M, Sweeney P, Lee LM. Date of first positive HIV test: reliability of information collected for HIV/AIDS surveillance in the United States. Public Health Rep. 2005;120(1):89-95.
27. Aalen OO, Farewell VT, De Angelis D, et al. A Markov model for HIV disease progression including the effect of HIV diagnosis and treatment: application to AIDS prediction in England and Wales. Stat Med. 1997;16(19):2191-2210.
28. Centers for Disease Control and Prevention. HIV prevalence, unrecognized infections, and HIV testing among men who have sex with men - five U.S. cities, June 2004-April 2005.MMWRMorb Mortal Wkly Rep. 2005;54(24):597-601.
29. Anderson JE, Carey JW, Taveras S. HIV testing among the general US population and persons at increased risk: information from national surveys, 1978-1996. Am J Public Health. 2000;90(7):1089-1095.
30. Centers for Disease Control and Prevention (CDC). HIV testing - United States, 2001. MMWR Morb Mortal Wkly Rep. 2003;52(23):540-545.
31. Santibanez SS, Garfein RS, Swartzendruber A, Purcell DW, Paxton LA, Greenberg AE. Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. J Urban Health. 2006;83(1):86-100.
32. Des Jarlais DC, Perlies T, Arasteh K, et al. Reductions in hepatitis C virus and HIV infections among injection drug users in New York City, 1990-2001. AIDS. 2005;19(suppl 3):S20-S25.
33. HIV/AIDS surveillance report, 2005. Vol 17, rev ed. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/hiv/topics/surveillance/ resources/reports/. 2007. Accessibility verified June 5, 2008.
34. Hall HI, Byers RH, Ling Q, Espinoza L. Racial/ethnic disparities in HIV prevalence and disease progression among men who have sex with men. Am J Public Health. 2007;97(6):1060-1066.
35. Centers for Disease Control and Prevention (CDC). Diagnosis and reporting of HIV and AIDS in states with HIV/AIDS surveillance - United States, 1994-2000. MMWR Morb Mortal Wkly Rep. 2002;51(27):595-598.
36. AIDS epidemic update 07. Joint United Nations Programme on HIV/AIDS (UNAIDS) Web site. http://data.unaids.org/pub/EPISlides/2007/2007_epiupdate_en. pdf. December 2007. Accessed January 23, 2008.
37. HIV counseling and testing at CDC-supported sites - United States, 1999-2004. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/hiv/topics/testing/reports.htm. 2006. Accessed April 30, 2007.
38. Karita E, Price M, Hunter E, et al. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS. 2007;21(4):403-408.
39. UNAIDS. Statement on the use of the BED-assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring: report of a meeting of the UNAIDS Reference Group for Estimates, Modeling and Projections; December 13-15, 2005; Athens, Greece.
40. Using the BED HIV-1 Capture EIA Assay to estimate incidence using STARHS in the context of surveillance in the United States. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/hiv/topics/surveillance/resources/ factsheets/BED.htm. October 2007. Accessibility verified June 5, 2008.
41. Centers for Disease Control and Prevention (CDC). Advancing HIV prevention: new strategies for a changing epidemic - United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52(15):329-332.
42. Centers for Disease Control and Prevention, HIV/ AIDS Prevention Research Synthesis Project. Compendium of HIV prevention interventions with evidence of effectiveness. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/hiv/resources/reports/hiv_compendium/index.htm. Revised November 1999. Accessibility verified June 5, 2008.
43. Warner L, Stone KM, Macaluso M, Buehler JW, Austin HD. Condom use and risk of gonorrhea and Chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies. Sex Transm Dis. 2006;33(1):36-51.
44. Sanchez T, Finlayson T, Drake A, et al; Centers for Disease Control and Prevention. Human immunodeficiency virus (HIV) risk, prevention, and testing behaviors - United States, National HIV Behavioral Surveillance System: men who have sex with men, November 2003-April 2005 [published correction appears in MMWR Morb Mortal Wkly Rep. 2006;55(27):752]. MMWR Surveill Summ. 2006;55(6):1-16.
45. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States. J Acquir Immune Defic Syndr. 2005;39(4):446-453.
46. Crepaz N, Lyles CM, Wolitski RJ, et al. Do prevention interventions reduce HIV risk behaviours among people living with HIV? a meta-analytic review of controlled studies. AIDS. 2006;20(2):143-157.